Eureka supports international innovative projects performed by consortia comprising SMEs, large companies, Research and Technology Organisations,  Universities and even end users on a variety of programmes (Clusters, Network Projects, Globalstars, Eurostars).

Somehow similar to Horizon Europe, provides higher success rates than HE and decentralised funding (by national funding agencies).

Its main characteristics are:

Aim: Eureka programmes typically supports the research & development of rapidly marketable innovative products, processes and services (commercialiation no later than 24/36 months after the termination of the project.

Beneficiaries: the project leader is an entity from a Eureka country (EU-27 + Associated countries: Albania, Argentina, Bosnia and Herzegovina, Bulgaria, Canada, Iceland, Israel, Montenegro, North Macedonia, Norway, Russia, San Marino, Serbia, Singapore, South Africa, South Korea, Switzerland, The Netherlands, Turkey, Ukraine, United Kingdom), leading a consortium comprised of at least 2 legal entities (10 on average) from at least 2 different (Member states or Associated) countries (5 on average).

Budget breakdown: typically from 1M€ to 15 M€ (gross numbers) depending on the type of instrument.

Maturity: TRL5-6 is expected at the end of the project.

Funding: around 50% funding rate (depending on countries and on type of entities).

Duration: less than 3 years.

Market introduction: within 2 years of the project’s completion.

Next calls: published on Eureka calls webpage, as well as on calls webpages from specific instrument websites.

Should you want more information please contact us.

Research and Innovation actions may include basic and applied research, technology development and integration, testing and validation on a small-scale prototype in a laboratory or simulated environment. Projects may contain closely connected but limited demonstration or pilot activities aiming to show technical feasibility in a near to operational environment. Brief information about this instrument is provided hereafter:

• Aim: to establish new knowledge and/or to explore the feasibility of a new or improved technology, product, process, service or solution. Topic-oriented.
• Beneficiaries: participation of typically from nine to twenty different legal entities, companies and/or research organisations, in a consortium. All consortium members established in EU Member States or in countries associated to Horizon Europe (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Serbia, Tunisia, Turkey, Ukraine, United Kingdom).
• Maturity: an initial Technology Readiness Level (TRL) around 3 is envisaged. TRL5/6 is expected at the end of the project.
• Duration: no more than 4 years.
• Funding: 100% funding rate. Requested EU contribution typically between 2€ million and 17€ million. Time-to-funding around 6 months.
• Next calls: published on the EC Funding and Tenders opportunities website.

Should you want more information please contact us.

Innovation actions may include prototyping, testing, demonstrating, piloting, large-scale product validation and market replication. While A ‘demonstration or pilot’ aims to validate the technical and economic viability of a new or improved technology, product, process, service or solution in an operational (or near to operational) environment, a ‘market replication’ aims to support the first application/deployment in the market of an innovation that has already been demonstrated but not yet applied/deployed in the market due to market failures/barriers to uptake. Brief information about this instrument is provided hereafter:

• Aim: to produce plans and arrangements or designs for new, altered or improved products, processes or services. Topic-oriented.
• Beneficiaries: participation of typically from nine to twenty different legal entities, companies and/or research organisations, in a consortium. All consortium members established in EU Member States or in countries associated to Horizon Europe (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Serbia, Tunisia, Turkey, Ukraine, United Kingdom).
• Maturity: an initial Technology Readiness Level (TRL) around 6 is envisaged. TRL8 is expected at the end of the project.
• Duration: no more than 4 years.
• Funding: 70% funding rate. Requested EU contribution typically between 1.4€ million and 12€ million. Time-to-funding around 6 months.
• Next calls: published on the EC Funding and Tenders opportunities website.

Should you want more information please contact us.

CSAs can comprise accompanying measures such as standardization, dissemination, awareness-raising and communication, networking, coordination or support services, policy dialogues and mutual learning exercises and studies (including design studies for new infrastructure and complementary activities of strategic planning, networking and coordination between programmes in different countries). Brief information about this instrument is provided hereafter:

• Aim: standardization, dissemination, awareness-raising and communication, networking, coordination or support services, policy dialogues and mutual learning.
• Beneficiaries: participation of typically from nine to twenty different legal entities, companies and/or research organisations, in a consortium. All consortium members established in EU Member States or in countries associated to HHorizon Europe (Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo, Moldova, Montenegro, New Zealand, North Macedonia, Serbia, Tunisia, Turkey, Ukraine, United Kingdom).
• Duration: no more than 4 years.
• Funding: 100% funding rate. Time-to-funding around 6 months.
• Next calls: published on the EC Funding and Tenders opportunities website.

.
Should you want more information please contact us.